Portfolio company
Cancilico
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cancilico develops AI-powered software for automated bone marrow cell classification and counting to assist diagnostic laboratories in identifying blood cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Moonlight AI
This company develops an artificial intelligence diagnostics platform that provides genomic insights from routine blood and marrow smear images for oncology laboratories.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Hema.to
This company develops clinical software that uses artificial intelligence to automate the analysis of flow cytometry data for diagnostic laboratories.
CanSense
This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Moonlight AI AG
This company develops image analysis software that detects genomic biomarkers from routine blood and cytology smears for clinical diagnostic laboratories.
